Hunan Warrant Pharmaceutical Co.,Ltd (SHA:688799)

Market Cap	6.92B +7.2%
Revenue (ttm)	1.49B +8.4%
Net Income	223.94M +53.9%
EPS	1.66 +50.4%
Shares Out	131.32M
PE Ratio	31.77
Forward PE	n/a
Dividend	0.18 (0.35%)
Ex-Dividend Date	Jul 1, 2026

Volume	5,666,335
Open	50.81
Previous Close	50.50
Day's Range	50.01 - 53.77
52-Week Range	40.51 - 66.88
Beta	0.14
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2026

About SHA:688799

Hunan Warrant Pharmaceutical Co.,Ltd manufactures and sells pharmaceutical products in China. It offers medicines in the areas of digestive, respiratory, anti-infective, diabetes, Hypertension, calcium supplementation cardiovascular, cerebrovascular, and other fields. The company also provides APIs and Intermediates. Hunan Warrant Pharmaceutical Co.,Ltd was founded in 2001 and is based in Changsha, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 1,291
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688799

Financial Performance

In 2025, SHA:688799's revenue was 1.50 billion, an increase of 6.46% compared to the previous year's 1.41 billion. Earnings were 238.28 million, an increase of 45.01%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 3, 2026

Data Sources Report a data error